Abstract
AbstractPoria cocosis used to treat various diseases because of its unique terpenes. However, no study verifying its modes of action using only its compounds based onin silicoexperiments has been conducted. Here, molecular docking and drug-induced transcriptome analyses were performed to confirm the modes of action ofPoria cocos. Additionally, a diffusion network analysis method was proposed to confirm its modes of action against Alzheimer’s. First,Poria cocosterpenes were collected from standard databases for molecular docking. They were then used for large-scale molecular docking using druggable proteomes, and the modes of action of lanostane and seco-lanostane, unique toPoria cocos, were confirmed. Additionally, the brain cell line was treated withPoria cocosto producePoria cocos-induced transcriptome data, and the transcriptome-based modes of action ofPoria cocoswere confirmed. Finally, a diffusion network was constructed using Alzheimer’s, which acts on both modes of action, and submodules of Alzheimer’s with which terpenes interact were identified. It was confirmed thatPoria cocosacts on the Wnt signaling pathway, Zn-to-anterograde axonal transport, autophagy impairment, insulin and AGE-RAGE signaling pathways, and apoptosis mechanisms. This study identified the modes of action ofPoria cocosusing biological data andin silicomethods.
Publisher
Cold Spring Harbor Laboratory
Reference130 articles.
1. Breitmaier E. Terpenes: flavors, fragrances, pharmaca, pheromones: John Wiley & Sons; 2006.
2. Comparative study of lanostane-type triterpene acids in different parts of Poria cocos (Schw;Wolf by UHPLC-Fourier transform MS and UHPLC-triple quadruple MS. J Pharmaceut Biomed,2015
3. Isolation of inhibitors of TPA-induced mouse ear edema from hoelen, Poria cocos;Chemical and pharmaceutical bulletin,1996
4. An Overview of the Applicability of Oryung-san as an Antihypertensive Agent;The Journal of Internal Korean Medicine,2017
5. Lee JH , Kim JI , Baeg MK , Sunwoo YY , Do K , Lee JH , et al. Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial. J Clin Med. 2019;8(10).